Skip to content

Clarivate CLVT Cash and cash equivalents, end of period

Cash and cash equivalents, end of period at other companies

Labcorp Holdings logo
Labcorp HoldingsLH

Other financials

Income statement

See full
Revenue$585.5M-1.4%
Gross profit$393.4M+1.7%
Operating income$30.2M+245%
Net income-$40.2M+61.3%
EPS (diluted)-$0.06+60.0%

Balance sheet

See full
Cash & equivalents$242.2M-31.6%
Total debt$4.4B-5.7%
Total equity$4.8B-4.7%
Total assets$10.9B-4.9%

Cash flow

See full
Operating cash flow$134.7M-21.3%
CapEx$55.8M-8.4%
Free cash flow$78.9M-28.5%

Valuation

See full
Market cap$1.27B-55.9%
Enterprise value$5.43B-24.5%
P/S0.5×-0.6×

Profitability

See full
Gross margin66.5%+0.5pp
Operating margin5%+2.9pp
Net margin-5.7%-2.5pp
FCF margin13.6%-0.4pp

Returns & leverage

See full
Return on equity-2.9%-1.2pp
Debt / equity0.9×0.0×
Current ratio0.8×0.0×

Where this comes from

Reported directly by Clarivate in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations.

The official record: Clarivate’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about Clarivate's cash and cash equivalents, end of period.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Clarivate's cash and cash equivalents, end of period?
Clarivate (CLVT) reported cash and cash equivalents, end of period of $242.2M in Q1 2026.
How has Clarivate's cash and cash equivalents, end of period changed year-over-year?
Clarivate's cash and cash equivalents, end of period decreased by 31.6% year-over-year, from $354M to $242.2M.
What is the long-term trend for Clarivate's cash and cash equivalents, end of period?
Over 2 years (2023 to 2025), Clarivate's cash and cash equivalents, end of period has grown at a -5.8% compound annual growth rate (CAGR), from $370.7M to $329.2M.